The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions
Current Medical Research and OpinionPublished 20 June 2005
Vasilios G. Athyros, Emmanuel S. Ganotakis, Moses Elisaf, Dimitri P. Mikhailidis
Citations188
SJR quartileQ2
SJR score0.79
SNIP0.76
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
MetS could be considered as a ‘normal’ variant if it was present in the majority of the population and the vascular risk associated with IDF-defined MetS may be low, raising cost-effectiveness issues.
Abstract
MetS could be considered as a 'normal' variant if it was present in the majority of the population. Moreover, the vascular risk associated with IDF-defined MetS could be low, raising cost-effectiveness issues. Alternatively, the new IDF definition may realistically reflect the current MetS epidemic. More studies are required to support or refute those interpretations.
Keywords
Medicine
JAMASummary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
27,886 Citations1993Scott M. Grundy
Dairy therapy remains the first line of treatment of high blood cholesterol, and drug therapy is reserved for patients who are considered to be at high risk for CHD, and the fundamental approach to treatment is comparable.
JAMAExecutive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
25,992 Citations2001Evaluation Expert Panel on Detection
Diabetic MedicineDefinition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation
15,141 Citations1998K. G. M. M. Alberti, Paul Zimmet +1 more
A WHO Consultation has taken place in parallel with a report by an American Diabetes Association Expert Committee to re‐examine diagnostic criteria and classification of diabetes mellitus and is hoped that the new classification will allow better classification of individuals and lead to fewer therapeutic misjudgements.
JAMAThe Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men
5,041 Citations2002Hanna‐Maaria Lakka
Cardiovascular disease and all-cause mortality are increased in men with the metabolic syndrome, even in the absence of baseline CVD and diabetes, according to the Kuopio Ischaemic Heart Disease Risk Factor Study.
Diabetes CareCardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
4,779 Citations2001Bo Isomaa, Peter Almgren +6 more
The WHO definition of the metabolic syndrome identifies subjects with increased cardiovascular morbidity and mortality and offers a tool for comparison of results from diferent studies.
Diabetes CareDiagnosis and Classification of Diabetes Mellitus
1,655 Citations2004American Diabetes Association
Diabetes CareA Comparison of the Prevalence of the Metabolic Syndrome Using Two Proposed Definitions
620 Citations2003Earl S. Ford, Wayne H. Giles
A universally accepted definition of the metabolic syndrome is needed and estimates differed substantially for some subgroups, however.
Current Medical Research and OpinionPrevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study
82 Citations2004Vasilios G. Athyros, Dimitri P. Mikhailidis +7 more
The prevalence of vascular disease was markedly increased in the presence of the MetSyn, followed by those with the Met Syn with or without diabetes mellitus without DM, which should be considered as a coronary heart disease-risk equivalent in future guidelines.
MetabolismTargeting vascular risk in patients with metabolic syndrome but without diabetes
65 Citations2005Vasilios G. Athyros, Dimitri P. Mikhailidis +8 more
A target-driven and intensified intervention aimed at multiple risk factors in nondiabetic patients with MetS substantially offsets its component factors and significantly reduces the estimated CVD risk.